Bottle Label 50 mg (71610 0241 30)
Losartan Potassium
Product Images NDC 71610-241
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71610-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure1 (Losartan Fig1)
This text appears to be a medical or scientific study regarding the drugs Atenolol and Losartan Potassium. The only identifiable information is the "Adjusted Risk Reduction" of 13% and a chart or graph showing study months. There is not enough context to determine the purpose or results of the study.*
Figure2 (Losartan Fig2)
Figure 3 (Losartan Fig3)
The text is not-readable.*
Figure-4 (Losartan Fig4)
This appears to be a statistical analysis or report of a clinical trial involving a medication called "Losttan Potassium" and a placebo. The text mentions the percentage of patients who experienced an "event" (not specified), with 60% of patients on Losttan Potassium and 40% on placebo experiencing the event. The report also states a risk reduction of 16.1% and a p-value of 0.022, which may relate to a comparison of the incidence of the event between the two groups. The text does not provide further details, and it is unclear what the specific outcomes or implications of the trial may be.*
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
